BackIGM Biosciences Overview

IGM Biosciences Other Liabilities

Latest other liabilities for IGMS: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

IGM Biosciences Other Liabilities History

Loading

IGM Biosciences vs. peers: Other Liabilities Comparison

Loading

IGM Biosciences Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

IGM Biosciences (IGMS) FAQ

IGM Biosciences (IGMS) currently reports a other liabilities of $0 as of June 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore IGM Biosciences's other liabilities history and peer comparisons.

IGM Biosciences's other liabilities changed from $0 to $0 (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IGM Biosciences reported $0 in other liabilities as of June 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IGM Biosciences, and consider following IGMS for alerts when major investors trade the stock.

IGM Biosciences is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IGMS with unrelated industries.